Literature DB >> 25961457

KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.

Heon Yung Gee, Fujian Zhang, Shazia Ashraf, Stefan Kohl, Carolin E Sadowski, Virginia Vega-Warner, Weibin Zhou, Svjetlana Lovric, Humphrey Fang, Margaret Nettleton, Jun-yi Zhu, Julia Hoefele, Lutz T Weber, Ludmila Podracka, Andrej Boor, Henry Fehrenbach, Jeffrey W Innis, Joseph Washburn, Shawn Levy, Richard P Lifton, Edgar A Otto, Zhe Han, Friedhelm Hildebrandt.   

Abstract

Steroid-resistant nephrotic syndrome (SRNS) is a frequent cause of progressive renal function decline and affects millions of people. In a recent study, 30% of SRNS cases evaluated were the result of monogenic mutations in 1 of 27 different genes. Here, using homozygosity mapping and whole-exome sequencing, we identified recessive mutations in kidney ankyrin repeat-containing protein 1 (KANK1), KANK2, and KANK4 in individuals with nephrotic syndrome. In an independent functional genetic screen of Drosophila cardiac nephrocytes, which are equivalents of mammalian podocytes, we determined that the Drosophila KANK homolog (dKank) is essential for nephrocyte function. RNAi-mediated knockdown of dKank in nephrocytes disrupted slit diaphragm filtration structures and lacuna channel structures. In rats, KANK1, KANK2, and KANK4 all localized to podocytes in glomeruli, and KANK1 partially colocalized with synaptopodin. Knockdown of kank2 in zebrafish recapitulated a nephrotic syndrome phenotype, resulting in proteinuria and podocyte foot process effacement. In rat glomeruli and cultured human podocytes, KANK2 interacted with ARHGDIA, a known regulator of RHO GTPases in podocytes that is dysfunctional in some types of nephrotic syndrome. Knockdown of KANK2 in cultured podocytes increased active GTP-bound RHOA and decreased migration. Together, these data suggest that KANK family genes play evolutionarily conserved roles in podocyte function, likely through regulating RHO GTPase signaling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25961457      PMCID: PMC4497755          DOI: 10.1172/JCI79504

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression.

Authors:  Moin A Saleem; Michael J O'Hare; Jochen Reiser; Richard J Coward; Carol D Inward; Timothy Farren; Chang Ying Xing; Lan Ni; Peter W Mathieson; Peter Mundel
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

2.  Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS.

Authors:  Rasheed A Gbadegesin; Gentzon Hall; Adebowale Adeyemo; Nils Hanke; Irini Tossidou; James Burchette; Guanghong Wu; Alison Homstad; Matthew A Sparks; Jose Gomez; Ruiji Jiang; Andrea Alonso; Peter Lavin; Peter Conlon; Ron Korstanje; M Christine Stander; Ghaidan Shamsan; Moumita Barua; Robert Spurney; Pravin C Singhal; Jeffrey B Kopp; Hermann Haller; David Howell; Martin R Pollak; Andrey S Shaw; Mario Schiffer; Michelle P Winn
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

3.  Nucleo-cytoplasmic shuttling of human Kank protein accompanies intracellular translocation of beta-catenin.

Authors:  Yong Wang; Naoto Kakinuma; Yun Zhu; Ryoiti Kiyama
Journal:  J Cell Sci       Date:  2006-09-12       Impact factor: 5.285

4.  Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner.

Authors:  Katsuhiko Asanuma; Kwanghee Kim; Jun Oh; Laura Giardino; Sophie Chabanis; Christian Faul; Jochen Reiser; Peter Mundel
Journal:  J Clin Invest       Date:  2005-04-01       Impact factor: 14.808

5.  Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible.

Authors:  Bernward Hinkes; Roger C Wiggins; Rasheed Gbadegesin; Christopher N Vlangos; Dominik Seelow; Gudrun Nürnberg; Puneet Garg; Rakesh Verma; Hassan Chaib; Bethan E Hoskins; Shazia Ashraf; Christian Becker; Hans Christian Hennies; Meera Goyal; Bryan L Wharram; Asher D Schachter; Sudha Mudumana; Iain Drummond; Dontscho Kerjaschki; Rüdiger Waldherr; Alexander Dietrich; Fatih Ozaltin; Aysin Bakkaloglu; Roxana Cleper; Lina Basel-Vanagaite; Martin Pohl; Martin Griebel; Alexey N Tsygin; Alper Soylu; Dominik Müller; Caroline S Sorli; Tom D Bunney; Matilda Katan; Jinhong Liu; Massimo Attanasio; John F O'toole; Katrin Hasselbacher; Bettina Mucha; Edgar A Otto; Rannar Airik; Andreas Kispert; Grant G Kelley; Alan V Smrcka; Thomas Gudermann; Lawrence B Holzman; Peter Nürnberg; Friedhelm Hildebrandt
Journal:  Nat Genet       Date:  2006-11-05       Impact factor: 38.330

6.  Mutations in EMP2 cause childhood-onset nephrotic syndrome.

Authors:  Heon Yung Gee; Shazia Ashraf; Xiaoyang Wan; Virginia Vega-Warner; Julian Esteve-Rudd; Svjetlana Lovric; Humphrey Fang; Toby W Hurd; Carolin E Sadowski; Susan J Allen; Edgar A Otto; Emine Korkmaz; Joseph Washburn; Shawn Levy; David S Williams; Sevcan A Bakkaloglu; Anna Zolotnitskaya; Fatih Ozaltin; Weibin Zhou; Friedhelm Hildebrandt
Journal:  Am J Hum Genet       Date:  2014-05-08       Impact factor: 11.025

7.  Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS).

Authors:  Jodi M Smith; Donald M Stablein; Ricardo Munoz; Diane Hebert; Ruth A McDonald
Journal:  Pediatr Transplant       Date:  2007-06

8.  A novel ankyrin repeat-containing gene (Kank) located at 9p24 is a growth suppressor of renal cell carcinoma.

Authors:  Shubhashish Sarkar; Badal Chandra Roy; Naoya Hatano; Teiichiro Aoyagi; Kazuo Gohji; Ryoiti Kiyama
Journal:  J Biol Chem       Date:  2002-07-19       Impact factor: 5.157

9.  Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  Kidney Int       Date:  1981-12       Impact factor: 10.612

10.  A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.

Authors:  Carolin E Sadowski; Svjetlana Lovric; Shazia Ashraf; Werner L Pabst; Heon Yung Gee; Stefan Kohl; Susanne Engelmann; Virginia Vega-Warner; Humphrey Fang; Jan Halbritter; Michael J Somers; Weizhen Tan; Shirlee Shril; Inès Fessi; Richard P Lifton; Detlef Bockenhauer; Sherif El-Desoky; Jameela A Kari; Martin Zenker; Markus J Kemper; Dominik Mueller; Hanan M Fathy; Neveen A Soliman; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

View more
  90 in total

1.  Kindlin-2 Association with Rho GDP-Dissociation Inhibitor α Suppresses Rac1 Activation and Podocyte Injury.

Authors:  Ying Sun; Chen Guo; Ping Ma; Yumei Lai; Fan Yang; Jun Cai; Zhehao Cheng; Kuo Zhang; Zhongzhen Liu; Yeteng Tian; Yue Sheng; Ruijun Tian; Yi Deng; Guozhi Xiao; Chuanyue Wu
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

Review 2.  Exploring the genetic basis of early-onset chronic kidney disease.

Authors:  Asaf Vivante; Friedhelm Hildebrandt
Journal:  Nat Rev Nephrol       Date:  2016-01-11       Impact factor: 28.314

3.  GAPVD1 and ANKFY1 Mutations Implicate RAB5 Regulation in Nephrotic Syndrome.

Authors:  Tobias Hermle; Ronen Schneider; David Schapiro; Daniela A Braun; Amelie T van der Ven; Jillian K Warejko; Ankana Daga; Eugen Widmeier; Makiko Nakayama; Tilman Jobst-Schwan; Amar J Majmundar; Shazia Ashraf; Jia Rao; Laura S Finn; Velibor Tasic; Joel D Hernandez; Arvind Bagga; Sawsan M Jalalah; Sherif El Desoky; Jameela A Kari; Kristen M Laricchia; Monkol Lek; Heidi L Rehm; Daniel G MacArthur; Shrikant Mane; Richard P Lifton; Shirlee Shril; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2018-06-29       Impact factor: 10.121

4.  Knockout of the neonatal Fc receptor in cultured podocytes alters IL-6 signaling and the actin cytoskeleton.

Authors:  Pantipa Tonsawan; James Dylewski; Linda Lewis; Judith Blaine
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-25       Impact factor: 4.249

5.  Structural basis for the recognition of kinesin family member 21A (KIF21A) by the ankyrin domains of KANK1 and KANK2 proteins.

Authors:  Qiong Guo; Shanhui Liao; Zhongliang Zhu; Yue Li; Fudong Li; Chao Xu
Journal:  J Biol Chem       Date:  2017-11-28       Impact factor: 5.157

6.  A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.

Authors:  Haiyang Yu; Mykyta Artomov; Sebastian Brähler; M Christine Stander; Ghaidan Shamsan; Matthew G Sampson; J Michael White; Matthias Kretzler; Jeffrey H Miner; Sanjay Jain; Cheryl A Winkler; Robi D Mitra; Jeffrey B Kopp; Mark J Daly; Andrey S Shaw
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

7.  Structural insights into ankyrin repeat-mediated recognition of the kinesin motor protein KIF21A by KANK1, a scaffold protein in focal adhesion.

Authors:  Wenfei Pan; Kang Sun; Kun Tang; Qingpin Xiao; Chenxue Ma; Cong Yu; Zhiyi Wei
Journal:  J Biol Chem       Date:  2017-12-07       Impact factor: 5.157

Review 8.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

9.  Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome.

Authors:  Hanna Debiec; Claire Dossier; Eric Letouzé; Christopher E Gillies; Marina Vivarelli; Rosemary K Putler; Elisabet Ars; Evelyne Jacqz-Aigrain; Valery Elie; Manuela Colucci; Stéphanie Debette; Philippe Amouyel; Siham C Elalaoui; Abdelaziz Sefiani; Valérie Dubois; Tabassome Simon; Matthias Kretzler; Jose Ballarin; Francesco Emma; Matthew G Sampson; Georges Deschênes; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2018-06-14       Impact factor: 10.121

Review 10.  Treatment of steroid-resistant nephrotic syndrome in the genomic era.

Authors:  Adam R Bensimhon; Anna E Williams; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2018-10-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.